Tags Clinical study

Tag: clinical study

Viaskin Patch Delivers Long-Lasting Peanut Desensitization After Phase IIb Trial

The study was designed to assess the long-term efficacy and safety of the treatment in subjects that had graduated from their earlier VIPES trial.

Peanut Allergy Treatment Receives Funding for Commercialization

"There’s a clear path to a marketable product here that could have tremendous impact globally."

Promising OIT Results from UNC Phase II Trial

"The first-ever clinical study of preschoolers allergic to peanuts could lead to safe and effective treatment for millions of people."

Study: New Gene Therapy Protects Against Anaphylaxis from Peanut Allergy

The technique could also be applied to other IgE-mediated food allergies.

Study: Risk of Food Allergies Only Minimally Higher in Siblings

Should younger siblings of children with food allergies be tested for allergy to foods even if they haven't shown symptoms?

Study: EPIT (Skin Patch) Therapy Provides Sustained Protection Against Anaphylaxis

The unique immune communication between skin and gastrointestinal tract can be used to generate long-lasting protection from food allergies.

Study: Blocking Histamine Receptors Suppresses Intestinal Anaphylaxis Caused by Peanut Exposure

The findings could lead to new therapies for the prevention and treatment of food allergies.

Viaskin Peanut, Milk and Egg Patch Therapies: Promising News from the AAAAI Conference

We are cautiously optimistic that a safe, effective, easy to administer treatment for food allergy may be on the horizon.

Study: False Positives are Common for Siblings of Children with Food Allergies

False positives generally lead to food avoidance which may increase the risk for developing an allergy later in life.

Breakthrough Food Allergy Therapies and the Big Business Behind Them

What it means to be a breakthrough therapy, who is developing them, how they work, and the (big) business drivers behind them.

Connect with Us

24,994FansLike
78FollowersFollow
3,465FollowersFollow
17SubscribersSubscribe